Sick Sinus Syndrome
Luigi Di Biase
<blockquote>
<p class="lessPadding">Dr. Luigi Di Biase is Section Head of Electrophysiology, Director of Arrhythmia Services, and Professor of Medicine (Cardiology) at Einstein/Montefiore. In addition, he serves as Senior Researcher at the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, Texas.</p>
<p>Improving patient care is the heart of Dr. Di Biase's mission. He believes that this is possible through dedicated clinical practice associated to cutting-edge clinical research. Dr. Di Biase's research focuses on cardiology and electrophysiology with specific emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. Additionally, his research focuses on heart failure, particularly cases treated with cardiac resynchronization therapy devices.</p>
<p>Dr. Di Biase, MD, PhD, FACC, FHRS, is a 2000 graduate (summa cum laude) of the medical school and a 2004 graduate (summa cum laude) of the cardiology residency program at the University of Bari, Bari, Italy. In 2006, he completed a second-level master degree in Electrophysiology and Pacing (summa cum laude) at the University of Insubria, Varese, Italy.</p>
<p>In 2007, Dr. Di Biase received a grant from the Italian National Society of Cardiology to pursue a research fellowship under the supervision of Dr. Andrea Natale at the Miller Family Heart & Vascular Institute at the Cleveland Clinic, Cleveland, Ohio. The following year, he accepted a position in cardiac electrophysiology at the University of Texas Medical School Branch in Galveston, Texas, where he continued to focus on his research projects at St. David's Medical Center under the leadership of Dr. Natale.</p>
<p>Dr. Di Biase was appointed Assistant Professor in 2007 at the University of Foggia, Italy, where he completed the PhD program in cardiovascular physiopathology in November 2010.</p>
<p>In 2009, Dr. Di Biase was appointed Adjunct Assistant Professor at the University of Texas at Austin, where he was promoted to Adjunct Associate Professor in 2012, the same year he joined Albert Einstein College of Medicine and Montefiore Medical Center with the title of Associate Professor, Department of Medicine (Cardiology).</p>
<p>In September 2014 Dr. Di Biase was appointed Section Head of Electrophysiology and Director of Arrhythmia Services at Einstein/Montefiore, while continuing to serve as Senior Researcher at the Texas Cardiac Arrhythmia Institute at St. David's Medical Center. </p>
<p>Subsequently Dr. Di Biase was promoted to the rank of Professor of Medicine, Department of Medicine (Cardiology).</p>
<p>Dr. Di Biase is the author of more than 450 publications in indexed journals, about 500 abstracts, and 18 electrophysiology book chapters. He has presented at numerous national and international conferences as an invited speaker.</p>
<p class="lessPadding">Dr. Di Biase is a member of the Italian Federation of Cardiology and Electrophysiology (FIC-AIAC), the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA), the American College of Cardiology (ACC), the American Heart Association (AHA), and a Fellow of the Heart Rhythm Society (FHRS), and the American College of Cardiology (FACC). He is also an honorary member of the Korean Society of Cardiology.</p>
<p class="lessPadding">Dr Di Biase serves as reviewer of major electrophysiology and cardiology journals, and as an editorial board member of <em>Heart Rhythm Journal</em>, <em>Heart Rhythm Journal Case Report</em>, and <em>Journal of Cardiovascular Medicine</em>. He is Associate Editor for <em>Journal Interventional Cardiac Electrophysiology (JICE)</em> and Associate Section Editor for <em>Pacing and Clinical Electrophysiology (PACE)</em>.</p>
<p class="lessPadding">Dr. Di Biase sees patients on both Einstein and Moses campuses of Montefiore Medical Center and at the Hutch Metro Center at Water Place.</p>
<p class="lessPadding"><strong><br /></strong></p>
<p class="lessPadding"><strong>More Information About Dr. Luigi Di Biase</strong></p>
<p class="lessPadding"><a href="http://www.einstein.yu.edu/departments/medicine/divisions/cardiology/ne… is More in Ablation for Ventricular Arrhythmia</a></p>
<p><a href="http://www.einstein.yu.edu/departments/medicine/divisions/cardiology/ne…; target="blank">Can the shape of the left atrial appendage affect stroke risk?</a></p>
<p><a href="http://www.einstein.yu.edu/departments/medicine/divisions/cardiology/ne…; target="blank">Continuous Warfarin Therapy for Patients Undergoing Catheter Ablation</a></p>
</blockquote>
<p>Improving patient care is the heart of Dr. Di Biase's mission. He believes this is possible through dedicated clinical practice associated to cutting-edge clinical research.</p>
<p>Dr. Di Biase's research focuses on cardiology and electrophysiology with specific emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. Additionally, his research focuses on heart failure, particularly cases treated with cardiac resynchronization therapy devices.</p>
<ol>
<li>Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, Gallinghouse GJ, Bailey SM, Zagrodzky JD, Santangeli P, Hao S, Hongo R, Beheiry S, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Al-Ahmad A, Wang P, Cummings JE, Schweikert RA, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Lewis WR, Natale A. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122:109-18. PMID 20606120.</li>
<li>Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, Lakkireddy D, Verma A, Khaykin Y, Hongo R, Hao S, Beheiry S, Pelargonio G, Della Russo A, Casella M, Santarelli P, Santangeli P, Wang P, Al-Ahmad A, Patel D, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Cummings JE, Schweikert RA, Lewis WR, Natale A. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation. 2010;121:2550-6. Epub 2010 Jun 1. PMID: 20516376.</li>
<li>Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, Gallinghouse GJ, Themistoclakis S, Rossillo A, Lakkireddy D, Reddy M, Hao S, Hongo R, Beheiry S, Zagrodzky J, Rong B, Mohanty S, Elayi CS, Forleo G, Pelargonio G, Narducci ML, Dello Russo A, Casella M, Fassini G, Tondo C, Schweikert RA, Natale A. Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management: Results From the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) Randomized Trial. Circulation. 2014 ;129:2638-44.</li>
<li>Di Biase L, Santangeli P, Burkhardt D, Bai R, Mohanty P, Carbucicchio C, Dello Russo A, Casella M, Mohanty S, Pump A, et al. Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2012; 60:132-141.</li>
<li>Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, Horton R, Sanchez JE, Bai R, Mohanty S, Pump A, Mauricio Cereceda Brantes, Gallinghouse GJ, Burkhardt JD, Federico Cesarani, Scaglione M, Natale A, Gaita F. Does the left atrial appendage morphology correlate with the risk of stroke in patients with AF? Result from a multicenter study. J Am Coll Cardiol. 2012;60:531-8.</li>
</ol>
<p>Luigi Di Biase, MD, PhD, FACC, FHRS, is Section Head of Electrophysiology and Director of Arrhythmia Services at Montefiore as well as Professor of Medicine (Cardiology) at our <a href="http://www.einstein.yu.edu/faculty/13629/luigi-di-biase/" target="_blank" rel="noopener noreferrer">Albert Einstein College of Medicine</a>.</p><p>Dr. Di Biase attended University of Bari in Bari, Italy, graduating from its medical school in 2000 and Cardiology residency program in 2004. In 2006, he completed a second-level master’s degree in Electrophysiology and Pacing at the University of Insubria, in Varese, Italy.</p><p>In 2007, Dr. Di Biase received a grant from the Italian National Society of Cardiology to pursue a research fellowship at the Miller Family Heart & Vascular Institute at the Cleveland Clinic. Dr. Di Biase completed the PhD program in cardiovascular physiopathology at the University of Foggia, Italy, in 2010.</p><p>Dr. Di Biase's research focuses on cardiology and electrophysiology, with an emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. His research focuses on heart failure, particularly in cases treated with cardiac resynchronization therapy devices.</p><p>Dr. Di Biase is the author of more than 450 publications in indexed journals, roughly 500 abstracts, and 16 electrophysiology book chapters. He has presented as an invited speaker at numerous national and international conferences and serves as Associate Editor for Pacing and Clinical Electrophysiology (PACE) as well as the Journal of Interventional Cardiac Electrophysiology (JICE). He is the Editorial Team Lead for the American College of Cardiology in the field of Electrophysiology. He co-authored the 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation, which is globally referenced for best-practices in cardiac ablation.</p><p>Dr. Di Biase is the highest published Electrophysiology faculty member and is also one of the world’s most published physicians on the topic of cardiac electrophysiology and atrial fibrillation.<br /><br /> Dr. Di Biase is a member of the Italian Federation of Cardiology and Electrophysiology (FIC- AIAC), the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA), the American College of Cardiology (ACC), and the American Heart Association (AHA). He is a fellow of the Heart Rhythm Society (FHRS) and the American College of Cardiology (FACC), and is an honorary member of the Korean Society of Cardiology.</p>
Lili Zhang
Non-invasive cardiology, echocardiography, cardio-oncology, multimodality cardiovascular imaging
Cardiotoxicity of cancer therapy, immune checkpoint inhibitor myocarditis, and the application of multimodality imaging and machine-learning techniques in cardiovascular disease.
<p>Lili Zhang, MD, is Director, Cardio-Oncology Program and Assistant Professor, Cardiology at Montefiore Einstein. A non-invasive cardiologist and a cardiac imaging specialist, Dr. Zhang’s clinical focus is in Cardio-Oncology, cardiomyopathy, general cardiology, echocardiography and multimodality cardiac imaging.</p><p>In 2007, Dr. Zhang earned her Doctor of Medicine degree at Peking University, Beijing, China. Further education and postdoctoral training brought her to the U.S., completing her Master of Science in Epidemiology at Johns Hopkins Bloomberg School of Public Health in 2011. She then came to Einstein, completing her residency in internal medicine in 2015 and her fellowship in cardiology in 2018. In 2019, Dr. Zhang completed her fellowship in Cardio-Oncology and cardiac imaging at Massachusetts General Hospital.</p><p>Dr. Zhang’s research focuses on cardiotoxicity of cancer therapy, immune checkpoint inhibitor myocarditis, cardiovascular care and the application of multimodality imaging and machine-learning techniques in cardiovascular disease. Her research experience includes retrospective studies, prospective cohorts (ARIC and CHS), large multi-cohort consortiums (CHARGE and PAGE consortiums), randomized clinical trials (PROMISE trial), and international collaborative registries (international immune checkpoint inhibitor myocarditis registry and Global Cardio Oncology Registry). She has shared her work through more than 60 manuscripts in peer-reviewed journals and abstract publications.</p><p>Dr. Zhang is board certified in Internal Medicine and Cardiovascular Disease. She is a Fellow of the American College of Cardiology, and is a member of the American Heart Association and the international Cardio-Oncology Society. In 2021, she was awarded the Glorney-Raisbeck Junior Faculty Research Award in Cardiovascular Disease by New York Academy of Medicine.</p>
Danny Woo
Samson Wiseman
Heather A. Trivedi
<p>Non-invasive imaging including transthoracic and transesophageal  echocardiography; stress testing; clinical cardiology; women's health. </p>
Mark I. Travin
Dr. Travin's <span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">clinical focus is on cardiac stress testing, radionuclide myocardial (perfusion and metabolic) imaging, and quantitative blood flow.</span><quillbot-extension-portal></quillbot-extension-portal>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Travin's research focus is on cardiac innervation radionuclide imaging with I-123 mIBG and analogous PET tracers, and quantitative blood flow assessment with myocardial perfusion PET.</span><quillbot-extension-portal></quillbot-extension-portal>
<p>Mark I. Travin, MD, FACC, MASNC, is Director of Cardiovascular Nuclear Medicine at Montefiore. He is also a Professor of Radiology and Medicine at our Albert Einstein College of Medicine. His clinical focus is on cardiac stress testing, radionuclide myocardial (perfusion and metabolic) imaging, and quantitative blood flow.</p><p>Dr. Travin earned his Bachelor of Science and Master of Science degrees in 1979 at Yale College, followed by his Doctor of Medicine degree in 1983 from the University of Pennsylvania School of Medicine. After graduating, he went on to complete both an internship and a residency in medicine at Lenox Hill Hospital. In 1986, Dr. Travin began a fellowship in cardiology at the Brown University Integrated Fellowship Program. After that, he went on to complete a clinical and research fellowship in medicine and cardiology, with emphasis in nuclear cardiology at Massachusetts General Hospital and Spaulding Rehabilitation Hospital. </p><p>Dr. Travin?s research focus is on cardiac innervation radionuclide imaging with I-123 mIBG and analogous PET tracers, and quantitative blood flow assessment with myocardial perfusion PET. He has a significant body of published research on cardiac imaging, and has received numerous awards and honors, including the Cardiology Program Director?s Training Award, and the American Society of Nuclear Cardiology 2015 Zaret-Beller Distinguished Journal of Nuclear Cardiology Service Award. </p>
Brian D. Spund
Mark Shlomovich
Albumin Dialysis
Care of children before and after solid organ transplantation
<p>Mark Shlomovich, MD, is Director, Extracorporeal Liver Support and Director, Pediatric Critical Care Transport at Children’s Hospital at Montefiore and Assistant Professor, Pediatrics at Montefiore-Einstein. Dr. Shlomovich’s clinical focus is on the care of critically ill children with abdominal organ failure, transplantation and post-surgical care. He also focuses on the safe transportation of critically ill children.</p><p>In 2006, Dr. Shlomovich earned his Bachelor of Science in biology from Towson University. He then attended University of Connecticut School of Medicine earning his Doctor of Medicine in 2010. His postgraduate training began at SUNY Downstate Medical Center with a four-year pediatric residency, where he was Chief Pediatric Resident in his final year. He then came to Children's Hospital at Montefiore for a pediatric critical care fellowship, which he completed in 2017.</p><p>Dr. Shlomovich’s research interests are in the use of artificial liver support technology, as well as the care of children in liver failure before and after transplantation. In addition, he investigates the safety and efficiency of the transportation of critically ill children. He has shared his research through peer-reviewed journals and abstracts, and is an ad hoc reviewer for BMC Nephrology.</p><p>Dr. Shlomovich is board certified in general pediatrics and pediatric critical care medicine. He is a member of the Society of Critical Care Medicine and the American Academy of Pediatrics.</p>
Jooyoung (Julia) Shin
<p align="left" style=" word-break: normal; text-align: left;"><span style=" color: black; font-size: 12.0pt; font-family: 'Times New Roman';">Clinical cardiology, specifically end-stage congestive heart failure, mechanical circulatory support, and cardiac transplantation.  </span></p>
Dr. Shin's clinical focus is on caring for patients with heart failure, particularly providing expertise in advanced heart failure, heart transplantation, and mechanical circulatory support.
Heart failure treatment is the primary focus of Dr. Shin’s research. She is the site principal investigator for the effectiveness of omecamtiv mecarbil/AMG 423 to treat chronic heart failure with reduced ejection fraction (GALACTIC-HF) and multiple cardiac sensors for the management of heart failure (MANAGE-HF) trials.
<p>Jooyoung Julia Shin, MD, is Fellowship Director, Advanced Heart Failure and Transplant Cardiology Fellowship Program and Associate Professor, Medicine at Montefiore Einstein. Dr. Shin’s clinical focus centers on heart failure, cardiac transplantation and mechanical circulatory support.</p><p>After obtaining her Bachelor of Science from the University of Michigan in 1994, Dr. Shin earned her Doctor of Medicine at George Washington University in 1999. She completed an internship and residency in internal medicine at the University of Maryland in 2002 before completing a cardiovascular disease fellowship at Emory University in 2005. Following this, Dr. Shin remained at Emory to complete an additional fellowship in advanced heart failure and transplant cardiology in 2006.</p><p>Dr. Shin’s research focuses on fellow education. She has been principal investigator and co-principal investigator on several funded research projects, and she has presented at invited lectures nationwide. Her work has also been published in numerous peer-reviewed journals, and she has been a reviewer for scientific publications, including the <em>Mayo Clinic Proceedings</em>, the <em>American Journal of Cardiology</em> and <em>Pacing and Clinical Electrophysiology</em>, among others.</p><p>Dr. Shin is board certified by the American Board of Internal Medicine in Cardiovascular Disease, Internal Medicine and Advanced Heart Failure and Transplant Cardiology. She is a member of the American College of Cardiology and the International Society for Heart and Lung Transplantation.</p>